Papillary thyroid cancer: Which Medications Are Safest? (83 Drugs Compared)
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
83 medications are used for Papillary thyroid cancer, with 995 combined adverse event reports. The most reported drugs for Papillary thyroid cancer are LENVATINIB and DABRAFENIB.
995
Total Reports
83
Drugs Used
All Medications for Papillary thyroid cancer Ranked by Safety Reports
| Drug | Brand | Reports | Deaths (all) | Hosp. (all) | Death Rate |
|---|---|---|---|---|---|
| LENVATINIB | Lenvima | 501 | 4,449 | 19,975 | 13.2% |
| DABRAFENIB | Tafinlar | 98 | 4,165 | 5,325 | 21.6% |
| SORAFENIB | sorafenib | 98 | 2,489 | 3,547 | 22.8% |
| LEVOTHYROXINE | LEVOTHYROXINE SODIUM | 53 | 4,539 | 12,155 | 7.4% |
| TRAMETINIB DIMETHYL SULFOXIDE | Mekinist | 51 | 3,925 | 3,438 | 24.1% |
| TRAMETINIB | - | 42 | 938 | 2,587 | 16.1% |
| SODIUM IODIDE I-131 | HICON | 32 | 29 | 51 | 7.8% |
| VEMURAFENIB | ZELBORAF | 26 | 1,040 | 2,368 | 12.1% |
| CABOZANTINIB S-MALATE | CABOMETYX | 19 | 4,203 | 6,193 | 10.7% |
| PEMBROLIZUMAB | KEYTRUDA | 16 | 15,543 | 35,472 | 18.6% |
| DOXORUBICIN | Doxorubicin Hydrochloride | 15 | 15,653 | 28,630 | 18.9% |
| SELPERCATINIB | RETEVMO | 14 | 160 | 342 | 14.8% |
| BINIMETINIB | MEKTOVI | 13 | 1,069 | 1,990 | 15.5% |
| ENCORAFENIB | BRAFTOVI | 13 | 1,397 | 2,334 | 16.3% |
| IPILIMUMAB | YERVOY | 13 | 8,043 | 17,031 | 22.0% |
| NIVOLUMAB | OPDIVO | 13 | 23,086 | 36,530 | 26.3% |
| LAROTRECTINIB | VITRAKVI | 12 | 149 | 151 | 18.7% |
| CISPLATIN | CISplatin | 11 | 8,387 | 17,469 | 17.7% |
| LENALIDOMIDE | LENALIDOMIDE | 10 | 35,942 | 86,495 | 10.3% |
| CABOZANTINIB | - | 9 | 767 | 2,771 | 20.0% |